Online Submissions

Already have a Username/Password for Jordan Journal of Pharmaceutical Sciences?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.


Author Guidelines


Jordan Journal of Pharmaceutical Sciences (JJPS) is a scientific peer-reviewed publication that focuses on current topics of interest in pharmaceutical sciences.

Preparation and Submission of Manuscripts

JJPS is a peer-reviewed Journal. It has been approved by the Higher Scientific Research Committee in the Ministry of Higher Education and Scientific Research. JJPS is a  bi-annual publication published by the Deanship of Academic Research-University of Jordan. JJPS will be a continuation of Dirasat.


Type of Manuscripts

JJPS publishes research articles, research reports, technical notes, scientific commentaries, news, and views.   

            Review Articles are only submitted to JJPS upon a request from the Editorial Board.


Scientific notes can also be submitted to JJPS according to following criteria:

1.      Maximum of 1500 words.

2.      Tables, figures: maximum of two.

3.      References: maximum of 15 references


Manuscript Preparation

The research paper should be typed on the computer; double spaced between lines, and shouldn't exceed 20 pages (5000 words, font size 13). Spelling, punctuation, sentence structure, spacing, length, and consistency in form and descriptions should be checked before submission. References should also be checked for accuracy. Ensure that all figures and tables are mentioned in the text, and that all references are cited in the text.


Title Page

The title should appear on a separate page and should be followed by the author(s) name(s) and the institution name and address. The title, author(s) name(s), and affiliations should all appear on their own respective line of text. Place an asterisk after the name of the author to whom enquiries regarding the paper should be directed and include that author's telephone and fax numbers and e-mail address. Author(s) affiliation(s) must be mentioned for each one in order.



Authors should submit with their research two abstracts, one in English and it should be typed at the beginning of the paper followed by the keywords before the introduction.

The abstract, detailing in one paragraph the problem, experimental approach, major findings, and conclusions, should appear on the second page. It should be double spaced and should not exceed 200 words for Full Papers and Reviews or l00 words for Notes and Rapid Communications.

Compounds mentioned in the abstract, given as specific Arabic numbers in the text, should also be accompanied in the abstract by that same numeral. The abstract should appear on a separate page and should be untitled.

The other abstract in Arabic should be typed at the end of the paper on a separate sheet, including author(s) name(s) and affiliation(s).


Should be included at the end of the abstract page, not exceeding 7 words both in Arabic and in English.



The manuscript should include an untitled introduction stating the purpose of the investigation and relating the manuscript to similar researches.


Results and Discussion

The results should be presented concisely. Tables and figures should be designed to maximize the presentation and comprehension of the experimental data. The discussion should interpret the results and relate them to existing knowledge in the field in a clear and brief fashion as possible. Authors submitting a manuscript as a Note should omit the heading Results and Discussion. For Full Papers of unusual length, subheadings may be included within the Results and Discussion section.

Bolded structural code numbers should only be used for new compounds and for those known compounds for which new biological data or spectroscopic values are being reported. Other known compounds should be referred to in the text by name, wherever necessary.


Experimental Section

The presentation of specific details about instruments used, sources of specialized chemicals and related experimental details should be incorporated into the text of the Experimental Section as a paragraph headed General Experimental.



The Acknowledgment section should include credits [initial(s) and last name(s)] for technical assistance, financial support, and other appropriate recognition.


References and Notes

References to the literature and all notes, regardless of their nature, should be numbered in order of appearance in the manuscript, and then cited under the heading References and Notes with superscript numbers. Each reference may have its own citation number, then should be assigned its own number in this section. References and notes should follow the format shown:



Taha M., Al-Bakri A. and Zalloum W. Discovery of potent inhibitors of pseudomonal quorum sensing via pharmacophore modeling and silico screening. Bioorg. Med. Chem. Lett. 2006; 16:5902-5906.



Ancel H. C., Allen L. V. and Popovich N. G. Pharmaceutical Dosage Forms and Drug Delivery Systems; Lippicott Williams & Wilkins: New York. 1999, p 45.

Chapter in a Book

Aburjai T., Natsheh F. and Qasem A.: In: Contemporary Perspective on Clinical Pharmaceutics. Kohli K. (Ed).; Elsevier New York, 2006; 1st edition, Chapter 57, pp 623-633.


Chemical or Biological Abstract

Al-Hiari Y., Qaisi A., El-Abadelah M. and Wolfgamg V., Monatshefte fuer

Chemei. 2006; 137(2) 243-248, Chem. Abstr. 2007; 145, 397308.


Ph.D. or M. Sc. Thesis

Alkhalil S. The Alkaloids of Thalictrum isopyroides. Ph.D. Thesis, Pittsburgh University, PA. 1986, p 115.



Davis R. U.S. Patent 5,708,591, 1998.

The author is responsible for the accuracy and completeness of all references.



It is the responsibility of the author(s) to provide correct nomenclature.

Insofar as possible, authors should use systematic names similar to those used by Chemical Abstracts Service.



Standard abbreviations should be used throughout the manuscript. All nonstandard abbreviations should be kept to a minimum and must be defined in the text following their first use. The preferred forms of some of the more commonly used abbreviations are: mp, bp, °C, K, s, min, h, mL, . µL, kg, g, mg, ng, µg, cm, mm, nm, mnl, mmol, , µmol, ppm, TLC, GC, HPLC, NMR, MS, UV, and IR.



The quality of the illustrations printed depends on the quality of the originals provided. Figures cannot be modified or enhanced by the journal production staff. Whenever possible, the graphic files furnished by authors on CD with revised submissions of accepted manuscripts are used in production of the Journal.

A-    Layout

In preparing structures for direct photoreproduction, layout is critical. Equations, schemes and blocks of structures are presented in the Journal either in one-column or two-column format.


B-     Content

Abbreviations such as Me for CH3, Et for C2H5 and Ph (but not Φ) for C6H5 are acceptable.


C-    Dimensions

For best results, illustrations should be submitted in the actual size at which they should appear in the Journal. Only original work or high quality photographic prints of originals should be submitted; photocopies do not reproduce well.

Chemical Structures

Structures should be produced with the use of a drawing program such as Chem-Draw. Structure drawing preferences are as follows:

1- Drawing settings:

Chain angle 120o

Bond spacing 18% of width

Fixed length 14.4 pt (0.508 cm, 0.2 in.), Bold width 2.0 pt (0.071 cm, 0.0278 in.), Line width 0.6 pt (0.021 cm,
     0.0084 in.), Margin width 1.6 pt (0.056 cm, 0.0222 in.), Hash spacing 2.5 pt (0.088 cm, 0.0347 in.)


2- Text settings:

Font: Arial/Helvetica

Size: 10 pt

3- Preference:

Units: points

Tolerance: 3 pixels

4- Page setup:

Paper: US Letter

Scale: 100%



These should be numbered consecutively with Arabic numerals and should be grouped at the end of the paper.

Footnotes in tables should be given lowercase letter designations and be cited in the table by italic superscript letter.



Figures should be constructed in keeping with the column width and line width. All illustrations should be numbered as "Figures", with Arabic numerals.


Informed Consent

All manuscripts reporting the results of experimental investigation involving human subjects should include a statement confirming that an informed consent was obtained from each subject or subject's guardian, after the approval of the experimental protocol by a local human ethics committee or IRB.


 Copyright Status Form

A properly completed Copyright Status Form with an original signature in ink must be provided for each submitted manuscript.


Manuscript Submission

Manuscripts (in English), together with a cover letter from the author responsible for all correspondence, should be submitted. Authors who prefer hardcopy submission should send the final version of the manuscript in quadruplicate (original and three copies). A CD (Floppy
Diskette is not accepted) containing all files should accompany the final accepted version of the manuscript. The version on the CD MUST exactly match the final version accepted in hardcopy. Check the CD with an up-to-date virus detection program as the presence of a virus may delay the publication of the manuscript. Label the disk with the manuscript number and the corresponding author name. Authors should take care to provide a valid e-mail address when submitting manuscripts.

Manuscript submission via e-mail is preferred:



Correspondence regarding accepted papers and proofs should be directed to Jordan Journal of Pharmaceutical Sciences.

Deanship of Academic Research

University of Jordan

Amman 11942, Jordan

Phone: +962 6 5355000 (25109).

Fax: +962 6 5355599




Galley Proofs

Page proofs will be sent to the author who submitted the paper. The standard delivery method for galley proofs is by mail. Reprints will be shipped within two weeks after the printed journal date. Corresponding authors will receive 50 free reprints.


Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  2. The submission file is in Microsoft Word document file format.

  3. The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

  4. If the author chooses to withdraw his article after it has been assessed, he hereby agrees to reimburse JJPS with the cost of reviewing the paper.

Copyright Notice

JJPS owns the copyright of each article it publishes. The author(s) has to get the approval of the Editor–in-Chief for any other uses of the article.


Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.